by | Jul 27, 2020 | Qavi, Abraham, Swat, Wojciech
— Technology Description
Researchers at Washington University in St. Louis have developed an improved method to monitor the progression of lymphoproliferative disorders (LPDs) and guide treatment decisions. LPDs, including leukemia and lymphoma, are characterized by the abnormal proliferation of blo…
by | Jul 22, 2020 | Guilak, Farshid, Pferdehirt, Lara
— Using CRISPR-based gene editing, decorin was inserted downstream of Smad7 to create autoregulated stem cells that can produce decorin. As Smad7 is activated during TGF-beta signaling, the stems cells produce decorin in response to TGF-beta. Decorin is a key modulator of extracellular matrix assembly…
by | Jul 20, 2020 | Mecham, Robert, Wagenseil, Jessica
— Mouse with floxed elastin gene to conditionally inactivate elastin gene expression.
Publication: Heterogeneous Cellular Contributions to Elastic Laminae Formation in Arterial Wall Development
by | Jul 17, 2020 | Covey, Douglas, Mennerick, Steven
— Technology Description
Researchers at Washington University in St. Louis have developed new compounds that may be used to treat alcohol use disorder (AUD). AUD, a common condition that takes a high personal and public health toll, is characterized by severe problems with drinking- sufferers may co…
by | Jul 9, 2020 | Gong, Yong-feng, Hou, Jianghui
— Disease indication: metabolic disorders including insulin resistance and diabetic nephropathy
Drug format: chemically modified synthetic microRNA (miRNA)
Drug class: first-in-class for metabolic disease
Research stage and Preliminary data:
Target: miR-29 mimics can increase the gene expressio…